National Bank of Canada’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,126
Closed -$42.3M 2827
2023
Q3
$42.3M Buy
+4,126
New +$445K 0.06% 260
2022
Q4
Sell
-986
Closed -$8.49M 2853
2022
Q3
$8.49M Buy
+986
New +$88K 0.05% 397

Other funds holding MRK

National Bank of Canada's MRK Position: Q2 2026 in Review

National Bank of Canada increased its Merck (MRK) stake by 24% in Q2 2026, buying an estimated $55.3M and bringing the position to 2,433,801 shares worth $313M. The position accounts for 0.22% of the portfolio, ranked #88.

National Bank of Canada first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $457M in Q4 2024. 2,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • National Bank of Canada held 2,433,801 shares of Merck worth $313M as of Q2 2026.
  • National Bank of Canada bought 472,411 Merck shares in Q2 2026, an estimated $55.3M.
  • Merck made up 0.22% of National Bank of Canada's portfolio in Q2 2026, its #88 holding.
  • National Bank of Canada first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • National Bank of Canada's Merck position peaked at $457M in Q4 2024.
  • 2,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.